chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tachycardia; tingly; dizzy/lightheaded; weak; nauseated; my heart was pounding; high blood pressure; I have had a very bad headache; This is a spontaneous report from a contactable consumer or other non health care professional. A 65-years-old non-pregnant female received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot no: EN6202, Expiry date not reported), via unspecified route of administration in left arm on 26Feb2021 at 02:15 (at age of 65-years-old) as dose 1, single for COVID-19 Immunization. Patient medical history includes chronic fatigue, migraines, tetanus vaccine (fever and sick), epinephrine (same reaction as the covid: vaccine: tachy, high BP, lightheaded, weakness, nausea for several hours; took me a few days to normalize), hypertension. Patient concomitant medications include metoprolol, flecainide, orphenadrine, fenofibrate used for unspecified indication from unknown date and unknown ongoing. Prior vaccination patient was not tested for COVID. Post vaccination patient was not tested for COVID. On 26Feb2021 at 14:30 (within 15 mins of vaccination), patient experienced tingly, dizzy, lightheaded, weak, nauseated, and her heart was pounding. Patient also experienced tachycardia and high blood pressure (184\116). That evening and the next 2 days patient had a very bad headache, weakness, dizziness, some nausea. Patient stated she is better, but still some headache, nausea, weakness. Patient had to visit emergency room due to events. Patient received treatment for events. The patient underwent lab test and procedure include blood pressure measurement was 184/116 and Electrocardiogram result was unknown on unspecified date. Facility type vaccine: Doctor's office/urgent care. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels; Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels; Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels; This spontaneous case was reported by a patient and describes the occurrence of LIVER FUNCTION TEST INCREASED (Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels), ASPARTATE AMINOTRANSFERASE INCREASED (Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels) and ALANINE AMINOTRANSFERASE INCREASED (Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051B22A, 014F21A, 007C21A and 020B21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jul-2022, the patient experienced LIVER FUNCTION TEST INCREASED (Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels), ASPARTATE AMINOTRANSFERASE INCREASED (Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels) and ALANINE AMINOTRANSFERASE INCREASED (Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels). At the time of the report, LIVER FUNCTION TEST INCREASED (Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels), ASPARTATE AMINOTRANSFERASE INCREASED (Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels) and ALANINE AMINOTRANSFERASE INCREASED (Had blood work on 15Jul2022 which showed elevated liver function tests, specifically the AST & ALT levels) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jul-2022, Alanine aminotransferase: increased. On 15-Jul-2022, Aspartate aminotransferase: increased.         No Concomitant medications were reported.  No Treatment information was provided.
Hospitalized (10.18.21);  COVID-19 positive (10.17.21);  fully vaccinated  Admission Date: 10/18/2021 Discharge Date: Oct 23, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia due to COVID-19 virus HOSPITAL COURSE: Patient is a 41 y/o man with past medical history significant for diabetes, CKD stage 5, hypertension and dyslipidemia presented to emergency department for shortness of breath. He presented to emergency department noted to have fever of 38.4, required non-rebreather and high-flow nasal cannula, creatinine of 7.5 under tested positive for COVID 19. For further evaluation by Nephrology patient was transferred to Hospital. On admission dexamethasone was started and Nephrology was consulted.  Nephrology evaluated patient and recommended PermCath. IR was consulted and PermCath was placed on 10/20. Dialysis was started on 10/20/2021 and continue daily for 3 days.  He was able to wean off of oxygen.  Due to high blood glucose levels while on dexamethasone Lantus dose is increased to 15 units at bedtime and started on sliding scale low-dose insulin. In stable condition patient is discharged home.
Woke up at 1:00am with chest pain. It lasted throughout the night so went to the ER. They performed an EKG and chest X-ray, both came out normal.
Woke up with intense chest pain on 12/31/2022 and went to the ER fearing a heart event. After testing it was determined that no heart attack had happened. Followed up with a cardiologist and they indicated the condition was Pericarditis. The symptoms eased within 24 hours and no adverse events have happened since.
Mixed COVID-19 vaccination series received; Intentional product misuse; This spontaneous case was reported by a nurse and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Mixed COVID-19 vaccination series received) and INTENTIONAL PRODUCT MISUSE (Intentional product misuse) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced INTENTIONAL PRODUCT MISUSE (Intentional product misuse). On 06-Aug-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Mixed COVID-19 vaccination series received). In April 2021, INTENTIONAL PRODUCT MISUSE (Intentional product misuse) had resolved. At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Mixed COVID-19 vaccination series received) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.  Patient stated that she had received one dose of Johnson& Johnson COVID-19 vaccine in April2021, prior to Moderna COVID-19 vaccine on 06Aug2021; Sender's Comments: This report refers to a case of Interchange of vaccine products and Intentional product misuse for mRNA-1273, lot # 037C21A with no associated AEs.
The vial was punctured more than 20 times.  This client was #23 vaccinated with the same vial
DOS 4-10-17 onset 2 days prior with papular lesions to lip and thigh progressing to vesicular Blisters/itchy- rhinorrhea -scabies lesions on exam.
Develope shortness of breathe and coughing  in September. I was not able to walk long distance, I had chest pain. I was treated as an asthma Flare up with steriods. No beinfit for steriods when to the ER I diagnosed with unprovoked pulmonary emboli in both lungs
Heart palpitations, muscle stiffness, facial numbness, extremity numbness, blurred vision, migraines.
Myalgia, Arthralgia, Fever, fatigue Narrative:  Other Relevant History:
Patient described extremity tremors, elevated temperature, severe discomfort all resulting in ER visit with 1 day admission.
Pain at injection site, soreness in right arm, Abdominal cramps and diarrhea lasting throughout the night
severe headache; body aches; This spontaneous case was reported by an other and describes the occurrence of HEADACHE (severe headache) and MYALGIA (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (severe headache) and MYALGIA (body aches). At the time of the report, HEADACHE (severe headache) and MYALGIA (body aches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
No additional AE; HCP reporting an improperly stored vaccine was administered to a patient. No additional details provided. No additional AE. No PQC.   ?    Names of vaccines involved: PROQUAD (Lot: W017567, Expiration Date: 29DEC2023) ?    Temperature: -11.8C ?; This spontaneous report was received from the registered nurse and refers to a patient of an unknown age and gender.  The patient's medical history, concurrent conditions, and concomitant therapies were not provided.  On 26-SEP-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, lot #W017567, expiration date: 29-NOV-2023, administered for prophylaxis (strength, and route of administration were not provided).  The vaccine was improperly stored (temperature: -11.8 Celsius degrees, time frame: 1 hour 45 minutes). No additional details, nor adverse events were provided.
Narrative: The patient received the third dose o Pfizer COVID 19 Vaccine and experinced severe malaise and myalgias to the point the patient could not move or get out of bed.
Caller is pt's son, reporting side-effects/reaction of the father, to Janssen COVID-19 Vaccine. All information collected was by the caller (pt's son) and not by the pt. The pt received the Janssen COVID-19 Vaccine Lot# 1805029 at facility 03/13/2021, time unknown. The following day, 03/14/2021 the pt was speaking incoherently, easily agitated, wasn't speaking to gf. The pt's history of ministrokes lead to the family calling 9-1-1. Pt was admitted to Medical Center on 03/14/2021. Pt vomitted, aspirated, was put on a ventilator, admitted to the ICU for 2-3 days and discharged 03/19/2021.  Pt takes Atorvastatin (Eliquis) 2.5mg bid, Furosemide 20mg qd, Lisinopril 40mg qd, Metropolol tartrate 12.5mg bid, and Folic Acid 1mg qd. Pt has a pacemaker and hypertension. Caller denies pt has any allergies. Currently the pt is only experiencing a loss of hearing. Caller was advised to take pt to primary doctor to have ears and hearing examined. Agent was consulted and Dr. was notified.
no additional events; 1st dose of GARDASIL 9 series over one year and just returned for second dose; This spontaneous report as received from a pharmacist refers to a 24 year old female patient. Information about concurrent condition, concomitant medication and medical history was not provided.   In approximately 2020 (reported as about a year ago), the patient received the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) series for prophylaxis. On 27-MAY-2021 the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for prophylaxis (Inappropriate schedule of vaccine administered). No product quality complaint or additional adverse event was reported.
12-18-20 at 0900 nausea and dry heaving started. 0920 felt freezing cold. 1000 feeling cold intensifies. 1000 headache begins. 1100 headache worsens. 1115 full body ache grows in strength. By 1200 body pain and fatigue increase. By 1300 headache and pain all over body maxes out at 8/10 on pain scale. For the rest of the day couldn?t warm up. Headache, body pain, and feeling cold lasted the rest of the day and throughout the night. 12-19-20 at 0730 headache extreme, body pain fading, feeling of cold not as intense. By 12-20-20 at 0600 only headache remains. feeling of cold, nausea,  and body pain are gone.
Headache beginning the day after the booster. Pain around the eyes, temples, forehead and back of head. The headache has been constant and continued until today's date. Ibuprofen and Tylenol help to manage the pain but it does not go away completely. Still present. It ranges from mild to moderate, usually not severe.
Expired Vaccine was Given; Initial Report Received on 15-Nov-2021  Non-Significant Information Received on 08-Dec-2021 and 09-Dec-2021 included confirmation of the date of vaccination with Heplisav-B and confirmation of the expiration date of 10-Aug-2021.  No additional information was provided.   A pharmacist in the reported that a 26 year-old female (race and ethnicity not provided) received an expired dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization.  No relevant medical history was reported. The patient was reported to have no known drug allergies.  No relevant concomitant medications were reported.    On 14-Nov-2021, the patient walked into the pharmacy and received an expired dose of HEPLISAV-B (Lot # 933624, expiration date 10-Aug-2021 and NDC #: 42528-003-003-01) in the left arm.   It was realized that the vaccine was expired after the injection was given.  No additional information was reported.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Narrative: COVID INFECTION AFTER COVID VACCINE 07/30 COVID vaccine dose #1 of 09/05 COVID-19 positive at healthcare system 09/08 Patient sends secure msg to PCP: "i tested positive for COVID-19 but not in the hospital, not doing well." asked for medication or advice 09/14 Patient calls telecare, c/o shortness of breath/chest tightness x 1 month; states "I went to ED on 09/07/2021, they told me I had pneumonia and they gave me some medications to go home with. I feel slightly better but no 100% yet, but I would like to repeat my chest x-ray 09/16 COVID test negative 09/29 requests to be tested again due to concern that pneumonia is not improving fast enough, persistent cough, requested for work clearance to ensure "still negative" 09/30 COVID test positive 10/01 COUGH RX W DOXYCYCLINE HYCLATE 100MG TAB & GUAIFENESIN 400 MG TAB, considered clinically resolved 10/19 NO SYMPTOMS
An associate of mine told me they got the vaccine on the 5th, then got the squirts the next day
This case was reported by a other health professional and described the occurrence of inappropriate age at vaccine administration in a 10-month-old male patient who received FLUARIX QUADRIVALENT (batch number 2A2KX, expiry date 26th June 2015). On an unknown date, the patient received FLUARIX QUADRIVALENT. On an unknown date, an unknown time after receiving FLUARIX QUADRIVALENT, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. It was unknown if the reporter considered the inappropriate age at vaccine administration and wrong vaccine administered to be related to FLUARIX QUADRIVALENT. Additional information received: A 10 months old was inadvertently given a dose of FLUARIX QUADRIVALENT.
Woke up the next morning feeling tired, constant headache, light sensitivity, both eyes are very red.
client driven by mother, c/o sharp chest pain 8/10, visibly upset, grimacing during inspiration.  paramedics on site were called and took vitals bp 100/65, 02 99%, HR 70.  After about 15minutes, pain was 3/10 resting, 5/10 during inspiration.  EKG conducted, WNL.  Client and mom AMA to be taken to the hospital.  Client stated she was feeling "a lot better" at 12p .  Mom said that she will drive client home and will go to ER if condition worsens.
Headache, nausea, vomiting, fever. Headache started at 5:00 AM 3/26/21 followed by vomiting approximately 2 hours later. Headache and fever last about 24 hours, nausea lasted 12 hours.
This spontaneous report as received from a physician, (physician received a call from a pharmacy) refers to a patient of unknown age and gender. No pertinent medical history or current conditions reported. On an unknown date the patient was vaccinated with an expired dose of GARDASIL. (That was patient's second dose). (Route, lot# and expiration date were not provided). Concomitant therapy was not provided. No adverse effect reported. Additional information has been requested.
Vaccine administered 2 days after expiration date vial was sealed and kept at recommended temperature prior to adminstration, no symptoms noted. No hospitalization
Immediately while receiving the injection I felt that the site very high, in fact it was injected into my left shoulder. I also immediately felt that the needle had to be forced harder than usual into my arm, - as if it was pushed through some tougher tissue than the typical muscle & soft tissue with shots. I could actually feel it forced through something like a membrane or cartilage into my shoulder.  I received the shot mid-afternoon & by late that evening my left arm was in severe pain from the shoulder down, so much so that it was very painful to just move my arm normally. This pain persisted for several days, I assumed this was a side effect from the flu vaccine that was mentioned as potentially occurring.  While the pain lessened somewhat over the following days, by 2 weeks later I realized that this was too long for a side effect & made an appointment to see a doctor for it.   I still had substantial pain & limited movement in my left arm a month later when I saw the Orthopedist  & now 9 months plus later I still have pain using my left arm in various normal day to day activities & simple movements.
Initial report received from a consumer on 27 June 2011. A female patient received a right arm intramuscular injection of ADACEL, sanofi pasteur lot number not reported, on 24 June 2011. On an unknown date, the patient experienced swelling of the arm, hardened area around injection site, soreness of the arm, unable to lift arm and tingling of arm from shoulder to fingers. The patient also had "fever" for one day the day after receiving the vaccine. She continues to have arm soreness, decreased range of motion and arm tingling. The outcome was reported as not recovered. Follow-up information was received from a health care professional on 09 August 2011. The lot number of the ADACEL was reported as sanofi pasteur Ltd. C3902 and sanofi pasteur Inc. lot number U3956BA. The patient was first seen on 27 June 2011 in Employee Health Services (EHS) with complaints of right arm swelling, and inability to lift arm. The patient was recommended to see a medical provider. On 29 June 2011, she was seen at an urgent care clinic and was given no lifting restrictions and range of motion exercise for a possible hematoma under the muscle with impingement. There was no diagnostic testing. On 13 July 2011, the patient provided a return to work release with no follow-up needed. No additional information available at this time. The outcome was reported as recovered. Documents held by sender: None.
Patient called to say she had dizziness that started a couple of hours after receiving her flu shot and had continued the next day. Patient had called the day after her shot and my supervisior had recommended she see a MD.
Breakthrough case admission after 2 vaccines Pfizer 3/31/21 Lot# ER8733;  Pfizer 4/21/21 Lot# EW0164
Fever 100.0; chills, headache, muscle pain -generalized, pain above eyes. Just stayed in bed and increased fluids, recovery 24 hours.
Information has been received from registered nurse concerning a 48 year old female patient with deep vein thrombosis, a pulmonary embolism, BACTRIM allergy and AUGMENTIN allergy, who on 22-DEC-2009 was vaccinated subcutaneously in the right arm with a 0.5 ml dose of PNEUMOVAX 23 (lot number 664864/1365Y). The same day the patient was vaccinated in the left arm with a dose of H1N1. Concomitant therapy included COUMADIN, TYLENOL and FLONASE. On 22-DEC-2009 the patient experienced localized red, circular, hot, itching and some swelling reaction. The nurses believed that intervention to prevent serious criteria were BENADRYL 25 mg every 6 hours, over the counter steroid creams to affected area and cold compresses. At the time of the report the patient was recovering. The patient called the nurse. No laboratory diagnostics studies were performed. Follow up information has been received from the nurse who reported that the lot # for the H1N1 was 102147P1. The nurse reported that she had spoken with the patient by phone on 28-DEC-2009. The symptoms had decreased, but the patient was still recovering. Additional information has been requested.
Collapsed twice, extremely low blood pressure (87/55), extreme dehydration, cramping of hands and feet, vomiting Most likely due to syncope Symptoms resolved approximately 12-18 hours first collapse
pt recvd vax;approx 1mo p/dose 1,while hiking,pt exp fatigue,dyspnea;subsequently devel n,indigestion,general joint aches,irritability,stiff neck & shoulder,ha,palpitations & hot flashes; unresolved
Swelling and tenderness of lymph nodes in neck and around collarbone of left side (injection was in left arm).
on 12/28,  this patient called us and informed us that on 12/25, she woke up with a headache, "muscle weakness" and nausea/vomiting which lasted one day.   She called of work on 12/25 and then stated that all symptoms resolved by 12/26. She did not seek any medical care and now is asymptomatic.
This spontaneous report was received from a Registered Nurse regarding multiple unspecified number of patients of unknown age and gender. Information on the concurrent conditions and medical history of the patients were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of ROTATEQ lot/batch # L033693 31-MAY-2017 (dose number, dose units, route and anatomical location were not specified). Concomitant medication were not reported. No adverse effect were reported. There were no product quality Concerns (PQC) involved. This is one of the several reports from the same reporter. Additional information has been requested.
approx 48hr post injection I experienced severe pain at site of injection radiating to my chest/rib area and could not get out of bed. I saw my doctor and discussed SIRVA(injury related to vaccine administration)and she stated" probably made up by ambulance chaser." I was  referred to physical therapy.  I read up on VAERS and spoke with the Infectious disease doctor for the County and she stated that my complaints are valid and that is why  I am filing VAERS report so late. She stated I should have received steroid treatment. I reported to my doctor that the injection had been given ^high in arm @acromion process, not in deltoid area as it should have been